The Chronic Lymphocytic Leukemia Channel is supported with funding from AstraZeneca (Diamond), AbbVie (Platinum), BeOne Medicines (Silver) and Lilly (Silver).
VJHemOnc is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
GCLLSG 2016 | Information on the iwCLL 2017 meeting
Stephan Stilgenbauer, MD, PhD of Ulm University, Ulm, Germany talks about the International Workshop on Chronic Lymphocytic Leukemia (iwCLL), which will be held in New York in 2017 (http://www.iwcll2017.org/). Prof. Stilgenbauer explains that the program for the iwCLL meeting has just been developed and is very exciting program focusing on the understanding of the disease biology, focusing on the new mutations, the new cancer driver pathways but also on functional interaction with the microenvironment. The meeting will discuss topics that are very relevant not only for disease biology but also as a basis for therapeutic approaches. Further, there will be the talks on new treatment developments, combined treatment modalities and new exciting current developments that are paving the road towards the cure of the disease.
Recorded at the 2016 International Workshop of the German CLL Study Group (GCLLSG) held in Cologne, Germany.
